225 related articles for article (PubMed ID: 27183391)
21. Mutation p.Leu128Pro in the 1A domain of K16 causes pachyonychia congenita with focal palmoplantar keratoderma in a Chinese family.
Dai L; Wu J; Guo H; Huang Y; Zhang K; Liu D; Fu L; Wu Y; Guan X; Bai Y; Liao Q
Eur J Pediatr; 2014 Jun; 173(6):737-41. PubMed ID: 24357266
[TBL] [Abstract][Full Text] [Related]
22. Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations.
Gruber R; Wilson NJ; Smith FJ; Grabher D; Steinwender L; Fritsch PO; Schmuth M
Br J Dermatol; 2009 Dec; 161(6):1391-5. PubMed ID: 19785597
[TBL] [Abstract][Full Text] [Related]
23. First case of pachyonychia congenita in the Czech Republic.
Jiráková A; Rajská L; Rob F; Džambová M; Sečníková Z; Göpfertová D; Schwartz M; Smith F; Lotti T; Hercogová J
Dermatol Ther; 2015; 28(1):10-2. PubMed ID: 25174302
[TBL] [Abstract][Full Text] [Related]
24. The phenotypic and molecular genetic features of pachyonychia congenita.
McLean WH; Hansen CD; Eliason MJ; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1015-7. PubMed ID: 21430705
[TBL] [Abstract][Full Text] [Related]
25. Keratin 16 regulates innate immunity in response to epidermal barrier breach.
Lessard JC; Piña-Paz S; Rotty JD; Hickerson RP; Kaspar RL; Balmain A; Coulombe PA
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19537-42. PubMed ID: 24218583
[TBL] [Abstract][Full Text] [Related]
26. The molecular genetic analysis of the expanding pachyonychia congenita case collection.
Wilson NJ; O'Toole EA; Milstone LM; Hansen CD; Shepherd AA; Al-Asadi E; Schwartz ME; McLean WH; Sprecher E; Smith FJ
Br J Dermatol; 2014 Aug; 171(2):343-55. PubMed ID: 24611874
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study.
Tan XL; Thomas BR; Steele L; Schwartz J; Hansen CD; O'Toole EA
J Am Acad Dermatol; 2022 Nov; 87(5):1172-1174. PubMed ID: 35245567
[No Abstract] [Full Text] [Related]
28. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
29. Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.
Kubo A; Oura Y; Hirano T; Aoyama Y; Sato S; Nakamura K; Takae Y; Amagai M
J Dermatol; 2013 Jul; 40(7):553-7. PubMed ID: 23662636
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of reported cases of pachyonychia congenita tarda.
Tatiane A; Slape D; Lawless R; Frew JW
Clin Exp Dermatol; 2019 Aug; 44(6):606-612. PubMed ID: 31074523
[TBL] [Abstract][Full Text] [Related]
31. Keratins K2 and K10 are essential for the epidermal integrity of plantar skin.
Fischer H; Langbein L; Reichelt J; Buchberger M; Tschachler E; Eckhart L
J Dermatol Sci; 2016 Jan; 81(1):10-6. PubMed ID: 26603179
[TBL] [Abstract][Full Text] [Related]
32. PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT
Tran HQ; Lee Y; Shin EJ; Jang CG; Jeong JH; Mouri A; Saito K; Nabeshima T; Kim HC
Mol Neurobiol; 2018 Oct; 55(10):7802-7821. PubMed ID: 29468562
[TBL] [Abstract][Full Text] [Related]
33. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.
Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R
Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339
[TBL] [Abstract][Full Text] [Related]
34. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
[TBL] [Abstract][Full Text] [Related]
35. Generalized bullae in a young girl with KRT6A-related pachyonychia congenita.
Liu J; Zhong W; Yu B; Lin Z; Zheng Y; Hu X
Pediatr Dermatol; 2020 Sep; 37(5):974-976. PubMed ID: 32662074
[TBL] [Abstract][Full Text] [Related]
36. Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: role of Nrf2-dependent gene expression and antioxidant enzymes.
Kleszczyński K; Ernst IM; Wagner AE; Kruse N; Zillikens D; Rimbach G; Fischer TW
Pharmacol Res; 2013 Dec; 78():28-40. PubMed ID: 24121007
[TBL] [Abstract][Full Text] [Related]
37. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
[TBL] [Abstract][Full Text] [Related]
38. Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation.
Harris K; Hull PR; Hansen CD; Smith FJ; McLean WH; Arbiser JL; Leachman SA
Br J Dermatol; 2012 Jan; 166(1):124-8. PubMed ID: 21790523
[TBL] [Abstract][Full Text] [Related]
39. Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway.
Dwivedi S; Rajasekar N; Hanif K; Nath C; Shukla R
Mol Neurobiol; 2016 Oct; 53(8):5310-23. PubMed ID: 26433376
[TBL] [Abstract][Full Text] [Related]
40. Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia.
Kerns M; DePianto D; Yamamoto M; Coulombe PA
Mol Biol Cell; 2010 Dec; 21(23):4068-75. PubMed ID: 20926689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
